Professor Peter's group at Baker IDI has unique expertise in molecular imaging technology identifying different components of vulnerable atherosclerotic plaques. This group is developing a highly sensitive narrow-range wavelength fluorescence catheter.
Vulnerable atherosclerotic plaques are the most important cause of cardiovascular mortality and morbidity worldwide. Detection of these plaques has an enormous health and economic potential. Our studies have shown conclusive results demonstrating fluorescence imaging could be used to detect vulnerable plaques and differentiate these from stable plaques reliably.
Non-confidential flyer